Vice Provost and Dean of Research
Showing 871-880 of 2,473 Results
-
Trevor Hastie
John A. Overdeck Professor, Professor of Statistics and of Biomedical Data Sciences, Emeritus
Current Research and Scholarly InterestsFlexible statistical modeling for prediction and representation of data arising in biology, medicine, science or industry. Statistical and machine learning tools have gained importance over the years. Part of Hastie's work has been to bridge the gap between traditional statistical methodology and the achievements made in machine learning.
-
Robert Hawkins
Assistant Professor of Linguistics and, by courtesy, of Psychology
BioI direct the Social Interaction & Language (SoIL) Lab at Stanford University. We're interested in the cognitive mechanisms that allow people to flexibly communicate, collaborate, and coordinate with one another. We work on these problems using large-scale, multi-player web experiments and computational models of language and social reasoning.
-
Melanie Hayden Gephart
Professor of Neurosurgery and, by courtesy, of Neurology and Neurological Sciences
BioI am a brain tumor neurosurgeon, treating patients with malignant and benign tumors, including gliomas, brain metastases, meningiomas, and schwannomas. I direct the Stanford Brain Tumor Center and the Stanford Brain Metastasis Consortium, collaborative unions of physicians and scientists looking to improve our understanding and treatment of brain tumors. My laboratory seeks greater understanding of the mechanisms driving tumorigenesis and disease progression in malignant brain tumors. We study how rare cancer cell populations survive and migrate in the brain, inadvertently supported by native brain cells. We develop novel cerebrospinal fluid-based biomarkers to track brain cancer treatment response, relapse, and neurotoxicity. Our bedside-to-bench-to-bedside research model builds on a foundation of generously donated patient samples, where we test mechanisms of brain cancer growth, develop novel pre-clinical models that reliably recapitulate the human disease, and facilitate clinical trials of new treatments for patients with brain cancer.
www.GephartLab.com
https://stan.md/BrainMets
@HaydenGephartMD -
Christopher Haynes
Director of Industry and Technology Transactions, Office of Technology Licensing (OTL)
BioChristopher Haynes is the Director of Industry and Technology Transactions within the Industrial Contracts Office, Office of Technology Licensing. In this capacity, Chris is responsible for the oversight of daily activities of the Industrial Contracts Office. Chris has extensive experience drafting and negotiating complex agreements and interfacing with research staff to ensure research objectives are met. Prior to joining Stanford, Chris's career has spanned both pharmaceutical and academic settings. His career experience includes previously roles as Senior Counsel - Licensing and Transactions at Sangamo Therapeutics, Inc., In-House Counsel - Worldwide Research and Discovery (WWRD) and Business Development (BD) at BioMarin Pharmaceutical, Inc., and Commercialization Manager and IP Counsel at the University of Louisville's Office of Technology Transfer.
-
Zihuai He
Associate Professor (Research) of Neurology and Neurological Sciences (Neurology Research), of Medicine (BMIR) and, by courtesy, of Biomedical Data Science
Current Research and Scholarly InterestsStatistical genetics and other omics to study Alzheimer's disease and aging.
